CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Klarna Group plc

KLAR
$6.79B
Mid Cap
NASDAQFinance ServicesFinancial technology🇺🇸North AmericaLONDON3.4K employees

Klarna is a Swedish financial technology company and digital bank. Founded in 2005 in Stockholm, Sweden, Klarna provides digital payments, short-term consumer credit, cards, banking services and merchant tools for online and in-store commerce. It is listed on the New York Stock Exchange and is best known for buy now, pay later payment products.

Website

Drugs in Pipeline

0

Phase 3 Programs

0

Upcoming Catalysts

1

Next Catalyst

Aug 13, 2026

4w

Market Overview

Stock performance and key metrics

KLAR News
Catalyst Timeline

1 upcoming, 0 past

Drug Pipeline

No drugs found in this phase.

Market-Implied Move
Regulatory Approvals

Frequently asked questions

When is Klarna Group plc's next FDA catalyst?

Klarna Group plc's (KLAR) next tracked catalyst is a Earnings expected August 13, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.

How do I track KLAR biotech catalysts?

Add KLAR to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Klarna Group plc's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply